Access to clinical trials for all patients is the only way to see advancements in treatment. A new research statement in Journal of Clinical Oncology features 4 recommendations to improve access through decentralization practices. Learn more: brnw.ch/21wLAaF

ASCO is now accepting applications for the October 2024 Hybrid FDA-ASCO Fellows’ Day Workshop through August 5: asco.smapply.org/prog/OctoberFe… Photo: Spring 2024 FDA-ASCO Fellows Day #OCEProjectSocrates

ASCO is now accepting applications for the October 2024 Hybrid FDA-ASCO Fellows’ Day Workshop through August 5: asco.smapply.org/prog/OctoberFe… Photo: Spring 2024 FDA-ASCO Fellows Day #OCEProjectSocrates

Sure to be a can’t-miss @myesmo - @asco session on development of precision therapeutics in oncology at #esmo24 Vivek Subbiah, MD Andres Cervantes ASCOPres

Selfie with @asco Asia Pacific Leadership Development Program members in Yokohama at #ASCOBT24 - how many amazing early career oncology superstars can you fit in one elevator?

Fun pre #ASCOBT24 sightseeing tour with Robin Zon, MD, FACP, FASCO in Kamakura ASCO

And tonight’s elevator selfie is with @asco Asia Pacific regional council members at #ASCOBT24 in Yokohama!

Tomorrow (August 8) is the 6th session of our free AAI Cancer Patient Navigation Digital Course! This week: How to Launch a Patient Navigation Program. Register here: us06web.zoom.us/webinar/regist…

🔸Spotted several ASCO IDEA recipients in this group of leaders committed to ending cancer as we know it through global collaboration!🚨IDEA applications are open now🚨— deadline Sept 30, 2024. 🔗👇 🔸Cheers to Robin Zon Julie Gralow Vanessa Eaton Mandy Davis Aitken and ASCO for

Kicking off @asco #ascobt24 meeting in Yokohama with great talk by Andrew Trister on AI and health systems.

#ASCOBT24 day 2 kicks off with keynote from Raffaella Casolino World Health Organization (WHO) on Building Equity in Cancer Care: From Policy to Action “Health is a right for all, not a privilege for a few”

Women at #ascoBT24 meet and greet - “Raising the Bamboo Ceiling” ASCO #WomeninOncology

The inspirational & transformative keynote sessions from #ASCOBT24 are now available to the public! Keynote topics cover how AI informs the learning health system, equity in cancer care, and targeting regulatory T cells (Tregs) in cancer. Watch here: brnw.ch/21wLMLT

.Peter Lee Microsoft Research discusses potential and pitfalls of AI. “I think the nervousness [among physicians] is a good thing, and I want people to feel reassured that their nervousness - anyone’s nervousness - about AI is not misplaced” ASCO dailynews.ascopubs.org/do/nervousness…

Now available: new recommendations for integrating #healthequity in our guidelines agenda: brnw.ch/21wLOjv OncTwitter #JCO

Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement Journal of Clinical Oncology ASCO ascopubs.org/doi/10.1200/JC…

Use of Prior Authorization in Medicare Advantage Exceeded 46 Million Requests in 2022 KFF kff.org/ded0780/

Save the date and register to attend Measuring Toxicity in Reproductive Organs during Oncology Drug Development – a 2 Day Virtual FDA-ASCO Workshop October 1 & 8. More details available here: ⤵️ fda.gov/news-events/fd… #FDAASCOWkshp24

.@asco board member and chair of ASCO AI Task Force Debra Patt discusses newly released ASCO principles for responsible use of AI in oncology. healio.com/news/hematolog…

If you are an early career cancer researcher, do apply for the CReDO NationalCancerGrid Convert your research idea into a full-fledged protocol ready for Ethics submission Opportunity to be mentored by the best cancer research faculty in the world (1/2)